UBS analyst Joshua Chan raised the firm’s price target on ABM (ABM) to $55 from $54 and keeps a Buy rating on the shares. Margin weakness in Q3 outweighs several positives, the analyst tells investors in a research note.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABM: